Literature DB >> 14574580

Cellular localization of orexins in human anterior pituitary.

Montserrat Blanco1, Rosalía Gallego, Tomás García-Caballero, Carlos Diéguez, Andrés Beiras.   

Abstract

Orexins A and B are hypothalamic peptides derived from a precursor called prepro-orexin and are associated with the stimulation of food intake and arousal. There is evidence that orexins act on some pituitary functions. Since no studies have been done concerning the presence of orexins in human pituitary, it is unclear whether the local effect of these peptides is due to orexins synthesized in the pituitary or to circulating-derived orexins. To define a possible paracrine regulatory role of orexins on pituitary cell function, we have sought to characterize the expression of orexins in the human adenohypophysis as well as to identify the cell types that express these proteins. In the present study, we used immunohistochemistry and double labeling to detect the presence of orexin A and orexin B in human pituitary. Orexin A was localized in 33% of pituitary cells. With double immunofluorescence techniques we demonstrated that orexin A is present in PRL (82 +/- 5.3%), TSH (18 +/- 2.3%), GH (10 +/- 2.3%), FSH (8 +/- 2.6%), and LH (7 +/- 3.2%) cells, but not in corticotroph cells. Orexin B was found in virtually all corticotrophs cells of the anterior pituitary. These results demonstrate that lactotroph cells are the main source of orexin A and corticotroph cells of orexin B. In summary the present findings provide the first evidence that orexins A and B are expressed in specific human pituitary cell types. Our data provide the cellular basis for a paracrine role of orexins in human pituitary cell function and further our understanding regarding the mechanisms by which orexins influence neuroendocrine function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14574580     DOI: 10.1007/s00418-003-0562-z

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  20 in total

1.  Cardiovascular regulatory actions of the hypocretins in brain.

Authors:  W K Samson; B Gosnell; J K Chang; Z T Resch; T C Murphy
Journal:  Brain Res       Date:  1999-06-12       Impact factor: 3.252

2.  Orexin-A augments voltage-gated Ca2+ currents and synergistically increases growth hormone (GH) secretion with GH-releasing hormone in primary cultured ovine somatotropes.

Authors:  Ruwei Xu; Qinling Wang; Ming Yan; Maria Hernandez; Changhong Gong; Wah Chin Boon; Yoko Murata; Yoichi Ueta; Chen Chen
Journal:  Endocrinology       Date:  2002-12       Impact factor: 4.736

3.  Neurons containing hypocretin (orexin) project to multiple neuronal systems.

Authors:  C Peyron; D K Tighe; A N van den Pol; L de Lecea; H C Heller; J G Sutcliffe; T S Kilduff
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

4.  Orexin-B augments voltage-gated L-type Ca(2+) current via protein kinase C-mediated signalling pathway in ovine somatotropes.

Authors:  Ruwei Xu; Sang-Gun Roh; Changhong Gong; Maria Hernandez; Yoichi Ueta; Chen Chen
Journal:  Neuroendocrinology       Date:  2003-03       Impact factor: 4.914

5.  Orexin receptors are expressed in the adrenal medulla of the rat.

Authors:  M López; R Señarís; R Gallego; T García-Caballero; F Lago; L Seoane; F Casanueva; C Diéguez
Journal:  Endocrinology       Date:  1999-12       Impact factor: 4.736

6.  Cellular localization of orexin receptors in human pituitary.

Authors:  M Blanco; M López; T García-Caballero; R Gallego; A Vázquez-Boquete ; G Morel; R Señarís; F Casanueva; C Diéguez; A Beiras
Journal:  J Clin Endocrinol Metab       Date:  2001-04       Impact factor: 5.958

7.  Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior.

Authors:  T Sakurai; A Amemiya; M Ishii; I Matsuzaki; R M Chemelli; H Tanaka; S C Williams; J A Richardson; G P Kozlowski; S Wilson; J R Arch; R E Buckingham; A C Haynes; S A Carr; R S Annan; D E McNulty; W S Liu; J A Terrett; N A Elshourbagy; D J Bergsma; M Yanagisawa
Journal:  Cell       Date:  1998-02-20       Impact factor: 41.582

8.  Somatotropic axis in hypocretin-deficient narcoleptic humans: altered circadian distribution of GH-secretory events.

Authors:  Sebastiaan Overeem; Simon W Kok; Gert Jan Lammers; Alla A Vein; Marijke Frölich; Arend E Meinders; Ferdinand Roelfsema; Hanno Pijl
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-11-26       Impact factor: 4.310

9.  Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.

Authors:  R M Chemelli; J T Willie; C M Sinton; J K Elmquist; T Scammell; C Lee; J A Richardson; S C Williams; Y Xiong; Y Kisanuki; T E Fitch; M Nakazato; R E Hammer; C B Saper; M Yanagisawa
Journal:  Cell       Date:  1999-08-20       Impact factor: 41.582

10.  Sympathetic and cardiovascular actions of orexins in conscious rats.

Authors:  T Shirasaka; M Nakazato; S Matsukura; M Takasaki; H Kannan
Journal:  Am J Physiol       Date:  1999-12
View more
  4 in total

Review 1.  Innovative techniques and applications in histochemistry and cell biology.

Authors:  Esther Asan
Journal:  Histochem Cell Biol       Date:  2003-11-28       Impact factor: 4.304

Review 2.  Paracrinicity: the story of 30 years of cellular pituitary crosstalk.

Authors:  C Denef
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

Review 3.  An overview of the orexinergic system in different animal species.

Authors:  Idris A Azeez; Olumayowa O Igado; James O Olopade
Journal:  Metab Brain Dis       Date:  2021-07-05       Impact factor: 3.584

4.  Neuroendocrine and sympathetic responses to an orexin receptor antagonist, SB-649868, and alprazolam following insulin-induced hypoglycemia in humans.

Authors:  Ameera X Patel; Sam R Miller; Pradeep J Nathan; Ponmani Kanakaraj; Antonella Napolitano; Philip Lawrence; Annelize Koch; Edward T Bullmore
Journal:  Psychopharmacology (Berl)       Date:  2014-04-26       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.